SCHEMBL8474802

SCHEMBL8474802

CCCNC1=Nc2sccc2S(=O)(=O)N1

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 1/20 0.35
UTS2R Q9UKP6 1/20 0.32
ADRA2A P08913 1/20 0.30
ADRA2B P18089 1/20 0.30
ADRA2C P18825 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8476774 0.92 UTS2R (0.34) UTS2R
SCHEMBL8473327 0.75
SCHEMBL8475635 0.71 ALDH1A1 (0.31)
SCHEMBL8478453 0.69 ALDH1A1 (0.34)
SCHEMBL7564894 0.67
SCHEMBL8474017 0.66 UTS2R (0.30) UTS2R
SCHEMBL8477373 0.65 ABCC8 (0.41)
SCHEMBL8477302 0.64 HCAR3 (0.31) UTS2R
SCHEMBL8475714 0.58 ABCC8 (0.40) UTS2R
SCHEMBL31379117 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5889002-A CENTRAL NERVOUS SYSTEM DISORDERS; CARDIOVASCULAR DISORDERS; RESPIRATORY SYSTEM DISORDERS; GASTROINTESTINAL DISORDERS; ENDOCRINAL DISEASES NOVO NORDISK A/S (DK) 1999-03-30 US disclosed
CN-1208417-A Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use NOVO NORDISK AS (DK) 1999-02-17 CN disclosed
EP-0876379-A1 FUSED 1,2,4-THIADIAZINE AND FUSED 1,4-THIAZINE DERIVATIVES, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1998-11-11 EP disclosed
WO-1997026265-A1 FUSED 1,2,4-THIADIAZINE AND FUSED 1,4-THIAZINE DERIVATIVES, THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1997-07-24 WO disclosed